Cancer deaths rise to 9.6 million as populations grow and age
By Health and Science Correspondent Kate Kelland LONDON (Reuters) – Cancer will claim the...
Read More
Updated
EU officials clash with Chinese firm on drug factory inspection
By Ben Hirschler LONDON (Reuters) – European medicines regulators have issued a notice that an ingredient for a generic brain cancer drug made in China does not meet manufacturing standards, after inspectors were refused...
Read MoreChina bans feeding of food waste to hogs in provinces with African swine fever
BEIJING (Reuters) – China has banned the use of food waste as pig feed in provinces that have reported African swine fever outbreaks as well as neighboring regions, the agriculture ministry said on Thursday, the latest...
Read More
FDA proposed crackdown on flavored e-cigs puts Juul on notice
By Yasmeen Abutaleb and Chris Kirkham WASHINGTON/LOS ANGELES (Reuters) – The U.S. Food and...
Read More
Exclusive: Brazil prosecutors seek leniency talks with BRF in food fraud probe
By Ana Mano PONTA GROSSA, Brazil (Reuters) – Brazilian federal prosecutors probing whether...
Read More
Saudi Arabia tells WTO it plans to adopt plain tobacco packaging
GENEVA (Reuters) – Saudi Arabia notified the World Trade Organization on Wednesday that it...
Read More
Zimbabwe police ban public gatherings in capital to contain cholera outbreak
HARARE (Reuters) – Zimbabwe’s police on Wednesday issued a ban on all public...
Read More
Egypt prosecutor says e-coli was factor in deaths of British tourists
CAIRO (Reuters) – Egypt’s public prosecutor said on Wednesday that e-coli bacteria...
Read More
Bristol-Myers plaque psoriasis drug shows promise in mid-stage trial
(Reuters) – Bristol-Myers Squibb said on Wednesday its experimental drug helped reduce the...
Read More
China bans live hog transport from 10 new regions to stem swine fever spread
By Dominique Patton and Hallie Gu BEIJING (Reuters) – China has banned the transport of live...
Read More
China’s small farmers pose huge challenge in swine fever battle
By Hallie Gu and Dominique Patton HARBIN, China (Reuters) – Even after 14 outbreaks of...
Read MoreTeva to hold Indivior generic drug launch pending U.S. ruling
(Reuters) – Teva Pharmaceuticals has agreed to hold off launching its knock-off version of Indivior Plc’s blockbuster opioid addiction drug until the resolution of a U.S. Court case on another generic rival, Indivior...
Read MoreFoamix acne drug meets main goals in late-stage trial, shares surge
(Reuters) – Foamix Pharmaceuticals Ltd said on Tuesday that its lead drug treating moderate-to-severe acne met the main goals of its third late-stage study, sending its shares up 57 percent in extended trading. FMX101, a...
Read MoreZimbabwe declares cholera emergency in capital after death toll rises to 20
HARARE (Reuters) – Zimbabwe declared a cholera outbreak in the capital Harare after 20 people died from the disease and more than 2,000 were infected by drinking contaminated water, new Health Minister Obadiah Moyo said on...
Read More
Nestle to remove stabilizers from major milk brands in Brazil
SAO PAULO (Reuters) – Nestle SA is eliminating stabilizers from two of its major milk brands...
Read MoreNZ’s Fisher & Paykel Healthcare files complaint in the U.S. against Resmed
(Reuters) – Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea...
Read More
Orexo soars after winning opioid drug appeal against Teva
By Jonathan Stempel (Reuters) – A U.S. appeals court on Monday revived Swedish...
Read More
Ebola fight has new science but faces old hurdles in restive Congo
By Fiston Mahamba BENI, Democratic Republic of Congo (Reuters) – When Esperance Nzavaki...
Read MoreU.S. appeals court invalidates Acorda patents on MS drug
By Jan Wolfe (Reuters) – A U.S. appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door to generic competition for the company’s flagship...
Read MoreConsort, Opiant to develop nasal spray for opioid overdose treatment
(Reuters) – Britain’s Consort Medical Plc said on Monday it had agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company Opiant Pharmaceuticals Inc. California-based Opiant...
Read More